DBV TECHNOLOGIES (EPA:DBV) | WebDisclosure

Basculer en Français

9801	Companies
196519	Keywords
127513	Articles
104469	Press releases

Home
Companies
DBV TECHNOLOGIES

PRESS RELEASE

published on 05/16/2024 at 22:30, 1 year 8 months ago

DBV Technologies annonce les résultats de son Assemblée Générale Mixte 2024
DBV Technologies annonce les résultats de son Assemblée Générale Mixte 2024 avec toutes les résolutions adoptées. La société se concentre sur le traitement des allergies alimentaires et autres affections immunologiques non satisfaites

Résultats Assemblée Générale Mixte DBV Technologies Allergies Alimentaires Options De Traitement
PRESS RELEASE

published on 05/16/2024 at 22:30, 1 year 8 months ago

DBV Technologies Announces Results of its 2024 Combined General Meeting
DBV Technologies announces successful results of its 2024 Combined General Meeting where shareholders approved all proposed resolutions. The Company focuses on treatment options for food allergies

Resolutions Combined General Meeting DBV Technologies Food Allergies Treatment Options
BRIEF

published on 05/09/2024 at 22:35, 1 year 8 months ago

DBV Technologies annonce sa participation à deux conférences investisseurs en mai

DBV Technologies Allergies Alimentaires JMP Sciences De La Vie H.C. Wainwright BioConnect Webdiffusion Conférence
BRIEF

published on 05/09/2024 at 22:35, 1 year 8 months ago

DBV Technologies announces its participation in two investor conferences in May

DBV Technologies Food Allergy JMP Life Sciences HC Wainwright BioConnect Conference Webcast
PRESS RELEASE

published on 05/09/2024 at 22:30, 1 year 8 months ago

Participation de DBV Technologies aux conférences investisseurs en mai
DBV Technologies participera aux conférences investisseurs en mai pour présenter les options de traitement des allergies alimentaires et conditions immunologiques, notamment avec sa plateforme Viaskin. Détails des événements disponibles sur le site web

Traitement Conférences Investisseurs DBV Technologies Allergies Alimentaires Viaskin
PRESS RELEASE

published on 05/09/2024 at 22:30, 1 year 8 months ago

DBV Technologies to Participate in Upcoming Investor Conferences
DBV Technologies to participate in two upcoming investor conferences in May, presenting its clinical-stage biopharmaceutical developments. Learn more about their innovative treatment options

Investor Conferences Biopharmaceutical DBV Technologies Food Allergies Immunologic Conditions
BRIEF

published on 05/07/2024 at 22:35, 1 year 8 months ago

DBV Technologies publie ses résultats financiers du premier trimestre 2024 et fait le point sur ses activités

Résultats Financiers DBV Technologies Efficacité Viaskin Peanut Nomination Affaires Réglementaires Évolution Trésorerie Essai Clinique VITESSE
BRIEF

published on 05/07/2024 at 22:35, 1 year 8 months ago

DBV Technologies publishes its financial results for the first quarter of 2024 and provides an update on its activities

DBV Technologies Financial Results Effectiveness Viaskin Peanut Regulatory Affairs Appointment Cash Flow Evolution VITESSE Clinical Trial
PRESS RELEASE

published on 05/07/2024 at 22:30, 1 year 8 months ago

DBV Technologies publie ses résultats financiers du premier trimestre 2024 et fait le point sur ses activités
DBV Technologies publie ses résultats financiers du premier trimestre 2024, recrutement en bonne voie pour VITESSE, nomination de Robert Pietrusko comme Directeur des Affaires Règlementaires

Résultats Financiers Affaires Réglementaires DBV Technologies VITESSE Robert Pietrusko
PRESS RELEASE

published on 05/07/2024 at 22:30, 1 year 8 months ago

DBV Technologies Reports First Quarter 2024 Financial Results and Business Update
DBV Technologies reports Q1 2024 financial results and business update, with VITESSE enrollment progress, appointment of Chief Regulatory Officer, and $101.5 million cash balance

Financial Results Q1 2024 DBV Technologies VITESSE Enrollment Chief Regulatory Officer

Accesswire

Published on 02/04/2026 at 13:30, 2 minutes ago

Nextech3D.ai Expands Krafty Lab Enterprise Engagement Platform with F-35 Flight Simulation Experiences Through The Squadron Partnership
Published on 02/04/2026 at 13:00, 32 minutes ago

NioCorp Applauds White House and EXIM For Bold "Project Vault" Initiative
Published on 02/04/2026 at 13:00, 32 minutes ago

Murchison Minerals Announces Assay Results From 2025 Diamond Drill Program At BMK VMS Deposit, All Holes Intersecting Significant Near-surface High-grade VMS Mineralization Including Precious Metals, Grades Up To 5.52% CuEq Or 21.97% ZnEq Including, 208g/
Published on 02/04/2026 at 02:15, 11 hours 17 minutes ago

Future Fuels Announces $2 Million LIFE Flow-Through Offering
Published on 02/04/2026 at 00:00, 13 hours 32 minutes ago

Sintana Energy Inc. Announces VMM-37 Resolution

View all ACCESSWIRE

EQS Group

Published on 02/04/2026 at 13:20, 12 minutes ago

Canary Islands fruit and vegetable sector strengthens its presence in European markets at Fruit Logistica
Published on 02/04/2026 at 13:10, 22 minutes ago

EPH Group AG adopts long-term dividend policy - Target payout ratio of 30% of net income for the year
Published on 02/04/2026 at 13:00, 32 minutes ago

EQS-Adhoc: EPH Group AG: Management Board and Supervisory Board determine future dividend policy
Published on 02/04/2026 at 12:56, 36 minutes ago

Coinsilium Group Limited: Warrant Exercise, Issue of Shares and Director Shareholding
Published on 02/04/2026 at 12:30, 1 hour 2 minutes ago

Alibaba Brings Cloud-Based AI Innovation to Milano Cortina 2026 Winter Olympics

Les Echos

Published on 02/04/2026 at 12:50, 42 minutes ago

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Published on 02/04/2026 at 11:59, 1 hour 33 minutes ago

LNA Santé : Répartition de capital et des droits de vote attachés aux actions au 31/01/2026
Published on 02/04/2026 at 11:51, 1 hour 40 minutes ago

Janvier 2026 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Published on 02/03/2026 at 19:18, 18 hours 13 minutes ago

Paulic Meunerie - Chiffre d'Affaires 2025
Published on 02/03/2026 at 18:00, 19 hours 32 minutes ago

Mint dépasse ses ambitions annoncées pour 2025 grâce à des succès commerciaux majeurs dans le BtoB

View all LES ECHOS COMFI WIRE